These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 14716146

  • 1. [Novel molecular approaches in the therapy of advanced colorectal carcinoma].
    Vanhoefer U.
    Onkologie; 2003 Dec; 26 Suppl 7():70-4. PubMed ID: 14716146
    [Abstract] [Full Text] [Related]

  • 2. Integration of novel agents in the treatment of colorectal cancer.
    Iqbal S, Lenz HJ.
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
    [Abstract] [Full Text] [Related]

  • 3. [Application of monoclonal antibody in combination with irinotecan in the treatment of colorectal cancer].
    Li J.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):796-7. PubMed ID: 17366800
    [No Abstract] [Full Text] [Related]

  • 4. Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancer.
    Jackson C, Cunningham D.
    Eur J Cancer; 2008 Mar; 44(5):652-62. PubMed ID: 18313913
    [Abstract] [Full Text] [Related]

  • 5. Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
    Venook AP.
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S74-84. PubMed ID: 19780248
    [Abstract] [Full Text] [Related]

  • 6. [The development of the first line treatment of metastatic colorectal cancer (mCRC)].
    Landherr L, Nagykálnai T.
    Magy Onkol; 2009 Sep; 53(3):237-46. PubMed ID: 19793687
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients.
    Vincenzi B, Santini D, Russo A, Silletta M, Gavasci M, Battistoni F, Di Cuonzo G, Rocci L, Gebbia N, Tonini G.
    Ann Oncol; 2006 May; 17(5):835-41. PubMed ID: 16507564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.
    Taniguchi H, Komori A, Narita Y, Kadowaki S, Ura T, Andoh M, Yatabe Y, Komori K, Kimura K, Kinoshita T, Muro K.
    Jpn J Clin Oncol; 2016 Mar; 46(3):228-33. PubMed ID: 26759349
    [Abstract] [Full Text] [Related]

  • 16. Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer.
    Larsen FO, Pfeiffer P, Nielsen D, Skougaard K, Qvortrup C, Vistisen K, Fromm AL, Jørgensen TL, Bjerregaard JK, Hoegdall E, Jensen BV.
    Acta Oncol; 2011 May; 50(4):574-7. PubMed ID: 21529301
    [Abstract] [Full Text] [Related]

  • 17. EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer.
    Sobrero AF, Maurel J, Fehrenbacher L, Scheithauer W, Abubakr YA, Lutz MP, Vega-Villegas ME, Eng C, Steinhauer EU, Prausova J, Lenz HJ, Borg C, Middleton G, Kröning H, Luppi G, Kisker O, Zubel A, Langer C, Kopit J, Burris HA.
    J Clin Oncol; 2008 May 10; 26(14):2311-9. PubMed ID: 18390971
    [Abstract] [Full Text] [Related]

  • 18. Irinotecan-cetuximab-bevacizumab as a salvage treatment in heavily pretreated metastatic colorectal cancer patients: a retrospective observational study.
    Feliu Batlle J, Cuadrado E, Castro J, Caldés T, Belda C, Sastre J, Barriuso J, Martínez Marín V, Díaz-Rubio E, González-Barón M.
    Chemotherapy; 2011 May 10; 57(2):138-44. PubMed ID: 21447947
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.